{"name":"Nanoform Finland Plc","slug":"nanoform-finland-plc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPd2lKYU9QTldQNndsd0dYandyWndLajQ0V3B4aHBkeEhVYTVlYTVJcW9nTUd1OTFRdlduU19haEVDOVRYcVdIcnE0TW9URGVZamhCSG9tX29QU0tpSVd2SHRUb3I5a3ZHRjhLZ0NnMmZGZUM2MlZ2aE1Pd3NWYmVTQS1ZQlh3QzVUSUdNQUNYZ291dkRrcVh3UEV5X2MxRDgxLUFFSTdTcXM5NFZoX3JVMlVPZTJfOFhPMlgyMWtUdE0wS1hhd3M1Nk15WmhEc3RMdlVLVzluVEg1Tmh5aG4tUnJWSQ?oc=5","date":"2026-02-13","type":"trial","source":"Fierce Pharma","summary":"Nanoform - Subcutaneously Administered Nanotrastuzumab Matches Performance of Herceptin HYLECTA in Minipig Study - Fierce Pharma","headline":"Nanoform - Subcutaneously Administered Nanotrastuzumab Matches Performance of Herceptin HYLECTA in Minipig Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxPLTM3SEhkYTk0eVdYRzVlUnZ0Um9rbnVpWjk2aUlJUGpiUWF5NW1jZDhiWmlUTWlsVzBRRWNFSUR2NUplcjhYRVFhSmFNa09zWTVXUmhfOHNlZkh3c2tRc3pxdEJiZldXdDZfNjRXRVRyUmNYNE8zTV9lWjRJaE9HR2l6UjBqd2NBV0tORHNIemJGUDJRWFN4TVpjUjFqN0ZscHA3eWs5S0FaVU11YUQwN0wtQzE5WjBJVlhNM3VoTEFZYnBtbTF5Q1U0R3pmbVBPYlVDSHhnTElaSVNJREZoZzlfcjBBR0pVcFlMb29DWC1mWXh2TlRvbTlCNkNUQWdlUmtPa0t4T29WMkk?oc=5","date":"2026-01-06","type":"pipeline","source":"TradingView","summary":"Inside information: Nanoform starts change negotiations as part of announced new midterm business targets for 2030 - TradingView","headline":"Inside information: Nanoform starts change negotiations as part of announced new midterm business targets for 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQSHE3bGR4OVFoR1hmTURMeHVkVnhJWEtBWkJLcDh5MF9kNEl1MHd4MXdiWS1YMHN4M3V6aTZYNGc1TlFmU1RsWlNOc3N0YTE3aHJfeUQtSzRLVnRYb0xpLVhpR0NjRTVndHExMFE5cnRhemd3cmFZVU1zUEpPNkJZSzBnWDNaSThnMDV4TU1HY1V2WHBtWjJ5RGxTbkJDbTk4b3lOQ3ltSXo2SDlYMmZEMGxDaHlJTHROdThQQ1hjZVYtQ19YOWpQNUlLYW1vZw?oc=5","date":"2025-11-12","type":"earnings","source":"Investing.com","summary":"Earnings call transcript: Nanoform Q3 2025 sees cash burn reduction, stock dips - Investing.com","headline":"Earnings call transcript: Nanoform Q3 2025 sees cash burn reduction, stock dips","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxOZTZENWlBcGdoX3lFM3RReUhXdFpwRmtnZUN4RG5Va3lwU1JTdFNCcm82VkxfWmhmakwwNU1XMUVSQ2dzSnhxRkNycW5xZVc4OHk4X3lwZ0NoQXhQUm51c1lMaVB3RFVTVFA1MTFEY0ppelZGOWZZMVlhZ2t0ZTNQX0t5SEt1amh0TV9OUFZxbWpMNGZWVWtNSXd6QzRCOWRrRU9ucU9OWlU4SVZKMUliVzNPdFl1R044T29zMmNMS0Y3MmNCb2xMV201UDR2WDRDZ0hmUzRrQld2OUxZaVh0d2phTWY2Y25aQ0dlWnBRckVqRzVLVzNPU1RzSmxIbklqaU5KVkxNSEVEaUUxeDBUM1pCc2NhWUZyQUY5ZQ?oc=5","date":"2024-10-29","type":"pipeline","source":"PR Newswire","summary":"Nanoparticle Drug Delivery Systems Market to Grow by USD 54.90 Billion (2024-2028) Driven by Chronic Diseases and AI Trends, Says Technavio - PR Newswire","headline":"Nanoparticle Drug Delivery Systems Market to Grow by USD 54.90 Billion (2024-2028) Driven by Chronic Diseases and AI Tre","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNZFk3YTNTdjROaEt6YVZJUHdRR3lJYmo5eHVkR0hHWno4TzBzeWRRb1NxeklOR1RiZm1HRnkwdEMwSy1JLWRLTVVMQkZVUVhaSDlGVGtNLXJBejlIeDdyNUw1VGlTM0VidV8xVjU5WFA0cTFwYUFoZEdISW5PUlJNM2VLZ2tyOGM4bjF5YTRyWFF3aHBWZHRTQ25CbEhod3p5Z3pvSUJXQ2h2ODVDeV9oRWxBOS1mTnhZbWd6RmxRRkZHSlY2VFh4MkkyM3d5eENGck5NcGh3LXdWalA5MWJyS0xYWWw5SG8yTngw?oc=5","date":"2024-04-12","type":"deal","source":"BioPharma APAC","summary":"Nanoform Finland Plc Partners with CBC Co., Ltd. to Transform Japanese Pharmaceutical Industry with Nanotechnology - BioPharma APAC","headline":"Nanoform Finland Plc Partners with CBC Co., Ltd. to Transform Japanese Pharmaceutical Industry with Nanotechnology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQdEtGZ2hfbk9GMkdUNU1FZFpsOWZlc3EzRjFHSFcwSkMtQ2xqM1JBVlprWVJudExrT2g2Mjg3NWF0ZWl2TW9tT19pXzdlN3ZXVG1JYVZpSWRyVGwtdWdUbXZTdm9pTUZTRDJsYi1LR3dudGR2amV1YTJYc3A3VnpEdzZwYw?oc=5","date":"2024-01-29","type":"pipeline","source":"Manufacturing Chemist","summary":"Nanoform announces clinical results for Enzalutamide cancer drug - Manufacturing Chemist","headline":"Nanoform announces clinical results for Enzalutamide cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOeUZTMXlzWVRZUFp3QjBtMV84R3dwcjVJekhsOFdVWTRKMXEtRGlCckdHVk9MWldBQVBqMHREMjRpNXpNRWJraGJROW1Tbk9PNW5saG96R3FCd0JveWEtaFJEUGdVbTZ5SjZ3Y3Rhekk3OEh1ZGNGOFFaR2hjbThCOUJaMU9vZDhVYS1DdjRuWHBsQ3lKTVNZVFhkZEhiU3ZFMW14ejJCOEdxMWRJWWc?oc=5","date":"2023-06-15","type":"pipeline","source":"Contract Pharma","summary":"Nanoform, Celanese Demonstrate Enhanced Drug Delivery Technology - Contract Pharma","headline":"Nanoform, Celanese Demonstrate Enhanced Drug Delivery Technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQYlRaalZNWEF5MUxwVlBKcnV5NUFjS216ZzNvMnpuMkFIYmxTbnBOZjVwZWdpQnVvdGpucFp1TVA5VmQxWlZEYUhsVm9xNTNFU01rRW02QXhrbkpvSmg3MUdGLUIxRmNJNXN1MU84eUszWVpFM3oyaGMxZXR4bUFXVmlVbFgwd1VMMlFRTE9saFRlcjFSVTNnRnlNSXNpc0NUcTN6U0pOZkhnV1hCbGc?oc=5","date":"2023-04-25","type":"pipeline","source":"Pharmaceutical Online","summary":"Controlled Expansion Of Supercritical Solutions (CESS®) Technology - Pharmaceutical Online","headline":"Controlled Expansion Of Supercritical Solutions (CESS®) Technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNZFNsd0FSaTU2Mlh6QVJSNmhpYmIzRktSaEc0bW9BbEIyR1llVG1HVzI2S0RQMzJvRUNiZUZfUk51MGF4RFdzSEFnYW56Nnh2aEo4QU03U1g5bm92WGc5MGF0WE1wRjY5MmhhbDRYU1VmaWM3X1FWLVlibWtUSEZCVm1VWU5Ma0dfVE5zTVRFU0xjNjNaaXhBUVFR?oc=5","date":"2023-03-24","type":"pipeline","source":"Pharmaceutical Online","summary":"Inspiring A New Era Of Patient-Centric Medicines - Pharmaceutical Online","headline":"Inspiring A New Era Of Patient-Centric Medicines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNeWtockx6RjR5OUFIZ0taQS1naVFyd0h6NENDZ2JMNVpuU29OekN3RUp5TjNuSWFvNjdldmgwWVVQLWFoS1Q5T1ZDTDlvZHZ6aEU3MEk3d1VRZml2OUNhVUgyZ0pwckxTQS1EQno0VVlJWEpiRmNwWk9QUGdrUnlZOWd2YlV2NlNDd3N1S1ZuZk1jQUQ1My1jQkxDRFpVbW5fX0VR?oc=5","date":"2019-07-12","type":"pipeline","source":"Manufacturing Chemist","summary":"Nanonisation: Tiny technology to turn drug failures to success - Manufacturing Chemist","headline":"Nanonisation: Tiny technology to turn drug failures to success","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}